A patient walked into my Epping rooms last month with a question that’s becoming the most common question I hear. She’d been on semaglutide for eighteen months. She’d lost twenty-eight kilograms. The cost was hurting. The nausea had never quite gone away. And nobody — not her GP, not the online prescriber she’d switched to last year, not the influencer whose protocol she’d followed — had told her what to do next.
“How do I stop?” she said. “Without it all coming back?”
This is a piece for her, and for the thousands of Australians now asking the same thing. It is written by a bariatric surgeon, so the bias is real — I will tell you when I think surgery is the right answer. But I will also tell you when it isn’t, and what the evidence actually shows about coming off GLP-1 medications safely.
What GLP-1 medications were designed to do
GLP-1 receptor agonists — semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and the rest of the family — were not designed to be temporary. They were developed to manage type 2 diabetes, which is a chronic condition. When they showed extraordinary weight-loss results as a side effect, the obesity indication followed.
That history matters. The molecules act on the brain and gut to dampen appetite, slow gastric emptying, and improve insulin sensitivity. They do this for as long as you take them. Stop the drug and the signalling reverts. Your appetite returns. Your fullness signals weaken. Your body — having spent months or years adapting to a lower weight — starts pushing you back toward your old set point.
The medications work. That part is not in dispute. The honest question is what happens when they stop.
What the data shows about regain
The clearest published data is the STEP 4 extension trial. Patients who had lost approximately 17% of their body weight on semaglutide were then randomised either to continue treatment or to switch to placebo. The continuation group held their weight. The placebo group regained roughly two-thirds of the lost weight within sixty-eight weeks.
The SURMOUNT-4 trial for tirzepatide showed something similar — about 14% rebound within a year of stopping.
The drugs do not “reset” your metabolism. They suppress hunger while you take them. The biology underneath stays the same.
This is not a failure of the medication. It is exactly what the molecular biology predicts. But it does mean that if you stop the drug without changing anything else, you can reasonably expect to regain most of the weight you lost. For a thirty-kilo loss, that’s twenty kilos back within twelve to eighteen months.
The three honest paths forward
When patients reach the point of wanting to come off injections, they are usually choosing between three real options. There is no perfect answer. There is only the answer that fits your biology, your budget, and your tolerance for ongoing medical treatment.
Path one — stay on the medication, indefinitely
For some patients, especially those whose weight loss has unlocked a much better quality of life and whose finances accommodate the cost, simply staying on the medication is a reasonable plan. The long-term safety profile through five-year follow-up is reassuring. Side effects often settle with time. Some patients do well on lower maintenance doses than the doses required to lose weight.
The honest catch: this is a lifelong financial commitment. In Australia, semaglutide for obesity is not PBS-subsidised. The cost is typically $400–500 per month. Over twenty years, that’s a six-figure spend.
Path two — taper slowly with intensive lifestyle support
This is the path most patients want, and it is also the path with the weakest evidence base. The theory is reasonable: if you taper the medication slowly over several months, while building rigorous nutrition and resistance-training habits, you may be able to hold a meaningful portion of the loss.
In practice, smaller observational studies suggest patients who do this carefully — with structured dietitian support, regular weigh-ins, and a willingness to re-introduce a low maintenance dose if regain begins — can hold thirty to fifty percent of their loss long-term. Some do better. Many do worse.
For this path to work, three things have to be true:
- You have to have built genuinely sustainable eating habits while on the medication — not just eaten less because you weren’t hungry.
- You have to have built lean muscle through resistance training. Muscle is metabolically active and protects against regain.
- You have to be willing to reintroduce the medication if your weight starts to climb. Most patients won’t, and regret it later.
Path three — transition to bariatric surgery
This is what brings most of my patients to my rooms. They have proved to themselves that their weight is responsive to biological intervention. They want a durable, one-time solution rather than an indefinite monthly prescription. They have, in effect, used the medication to demonstrate that weight loss is possible — and they now want to lock it in.
The good news: GLP-1 history is not a barrier to surgery, and in many cases it makes surgery safer. Patients who present to me having already lost twenty or thirty kilograms have lower operative risk, smaller livers, and easier laparoscopic exposure than they would have at their pre-medication weight.
One important clarification
You do not need to regain weight to qualify for bariatric surgery. We assess your eligibility on your pre-medication BMI and comorbidity profile. If you were a candidate before you started injections, you remain a candidate after.
How we structure the offramp at OptiWeight
If you and I decide together that surgery is the right next step, the path looks roughly like this.
- Discovery call. A free fifteen-minute conversation to understand where you’re at, what medication and dose you’re on, and what you’re hoping for. No commitment.
- First consultation. A forty-five-minute appointment where we map out which procedure fits your physiology, your comorbidities, and your life. We confirm your eligibility using pre-medication weight.
- Pre-operative workup. Gastroscopy, sleep study if indicated, baseline blood tests. This typically takes six to eight weeks.
- Medication taper. Most patients stop GLP-1 medications four weeks before surgery. The slower withdrawal allows your appetite signals to return so you don’t feel ambushed in the post-operative period.
- Dietitian-led liver-reducing diet. Two weeks immediately pre-op. This shrinks the liver to make the laparoscopic field safer.
- Surgery. Sleeve gastrectomy in most cases. Roux-en-Y bypass if reflux, diabetes, or higher BMI tips the calculation that way.
- Long-term follow-up. 2-week, 6-week, 12-week, 6-month and 12-month reviews — then every 6–12 months for life. This is the bit that determines whether weight loss is durable.
“Surgery does not make you regret the medication. It builds on top of it.”
The questions I hear most
Will I lose more weight after surgery?
Usually yes. Most patients who transition from GLP-1 medications to a sleeve gastrectomy lose a further fifteen to twenty-five percent of their pre-surgery body weight. Combined with what they’ve already lost, total weight loss often exceeds what either pathway would have delivered alone.
Will I get GLP-1 side effects back, or new ones from surgery?
Nausea, constipation and reflux can occur after sleeve gastrectomy. They usually settle within the first three to six months. The intensity is generally less than the early weeks of GLP-1 titration. We will warn you about all of this honestly at consultation.
Should I stop the injection now and wait, or stay on it until surgery?
Stay on it until we decide together. Sudden cessation of GLP-1 medications before any plan is in place is the worst of both worlds — you face regain without the structured support that makes surgery durable. We will plan the taper deliberately, with a clear surgical date in view.
What I want you to take away from this
You did not fail GLP-1 medications. They are doing exactly what they were designed to do. If you want to come off them, you need a plan that respects the biology — either a different long-term tool, or an honest commitment to one of the other paths.
If you’d like to know whether surgery is a reasonable next step for you, the sixty-second quiz on this site is built specifically for this conversation. It will not pressure you. It will not market to you. It will give you a real answer based on your circumstances.
And if surgery isn’t right for you, we’ll tell you that honestly too.
